This case also demonstrates the dose-dependent and reversible nature of PI3K inhibitor-associated hyperglycemia, and thus the effectiveness of PI3K inhibitor cessation or dose reduction to mitigate hyperglycemia. This evidence concerns the gene PIK3CA and Hyperglycemia.